Evidence map›Paper›PMID 28903310›Full record

ArticleOncotarget2017

Characterization of physiochemical properties of caveolin-1 from normal and prion-infected human brains.

Xiangzhu Xiao, Pingping Shen, Zerui Wang, Johnny Dang, Alise Adornato, Lewis S Zou, Zhiqian Dong, Jue Yuan, Jiachun Feng, Li Cui and 1 more

Abstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. A New Take on Prion Protein Dynamics in Cellular Trafficking.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xiangzhu Xiao *Department of Pathology, Case Western Reserve University, Cleveland, OH, USA.
Pingping Shen *Department of Pathology, Case Western Reserve University, Cleveland, OH, USA.
Zerui Wang *Department of Pathology, Case Western Reserve University, Cleveland, OH, USA.
Johnny DangDepartment of Pathology, Case Western Reserve University, Cleveland, OH, USA.
Alise AdornatoDepartment of Pathology, Case Western Reserve University, Cleveland, OH, USA.
Lewis S ZouDepartment of Pathology, Case Western Reserve University, Cleveland, OH, USA.
Zhiqian DongDepartment of Pathology, Case Western Reserve University, Cleveland, OH, USA.
Jue YuanDepartment of Pathology, Case Western Reserve University, Cleveland, OH, USA.
Jiachun FengInstitute of Neuroscience Center and Neurology Department, The First Hospital of Jilin University, Changchun, Jilin, China.
Li CuiInstitute of Neuroscience Center and Neurology Department, The First Hospital of Jilin University, Changchun, Jilin, China.
Wen-Quan ZouDepartment of Pathology, Case Western Reserve University, Cleveland, OH, USA.

Funding

Pathogenicity of prion protein aggregates from uninfected cells and brainsR01NS062787 · NINDS · CASE WESTERN RESERVE UNIVERSITY · PI ZOU, WEN-QUAN · 2009 to 2013
$1.4M
Generating iPSC-derived Neurons to Explore Formation & Inhibition of Human PrionsR21NS087588 · NINDS · CASE WESTERN RESERVE UNIVERSITY · PI QI, XIN, TESAR, PAUL JOSEPH · 2014 to 2015
$436k
Accessing transmissibility and diagnostic marker of skin prions.R21NS096626 · NINDS · CASE WESTERN RESERVE UNIVERSITY · PI KONG, QINGZHONG, SAFAR, JIRI G. · 2016 to 2017
$436k
NINDS NIH HHS R01 NS062787NINDS NIH HHS R21 NS087588NINDS NIH HHS R21 NS096626
6 · The paper itself

Abstract

Caveolin-1 is a major component protein of the caveolae-a type of flask shaped, 50-100 nm, nonclathrin-coated, microdomain present in the plasma membrane of most mammalian cells. Caveolin-1 functions as a scaffolding protein to organize and concentrate signaling molecules within the caveolae, which may be associated with its unique physicochemical properties including oligomerization, acquisition of detergent insolubility, and association with cholesterol. Here we demonstrate that caveolin-1 is detected in all brain areas examined and recovered in both detergent-soluble and -insoluble fractions. Surprisingly, the recovered molecules from the two different fractions share a similar molecular size ranging from 200 to 2,000 kDa, indicated by gel filtration. Furthermore, both soluble and insoluble caveolin-1 molecules generate a proteinase K (PK)-resistant C-terminal core fragment upon the PK-treatment, by removing ˜36 amino acids from the N-terminus of the protein. Although it recognizes caveolin-1 from A431 cell lysate, an antibody against the C-terminus of caveolin-1 fails to detect the brain protein by Western blotting, suggesting that the epitope in the brain caveolin-1 is concealed. No significant differences in the physicochemical properties of caveolin-1 between uninfected and prion-infected brains are observed.

Indexed as

aggregationcaveolin-1Gerotargethuman brainprion diseasesolubility

Identifiers

PMID28903310
PMCPMC5589549

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.